arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

Lifevantage Corp

LFVN
$5.08 ▼ -0.84 (-14.25%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
17 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
68
Health
Good
Neutral
auto_awesome

Analytical Summary

Lifevantage Corp shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $63.7M
Dividend Yield 3.64%
Revenue Growth -20.1% ↘
Op. Margin 3.3% ↘
ROIC 15.2% ↘
FCF / Share $0.53 ↘
Trailing P/E 12.7x
Price / Book 1.9x
FCF Yield 10.5%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$182.59M
↓ -20.1% —
Net Income Profit after all expenses
$5.07M
↓ -48.3% —
Operating Margin Operating profit as % of sales
3.3%
↓ -37.4% 38th
FCF / Share Free cash flow per share
$0.53
↓ -38.0% —
Long-Term Debt Long-term obligations
$0.00
↓ -100.0% —

Health Breakdown

Profitability ↑
38
Returns ↑
72
Financial Health ↓
98
Cash Quality ↓
76

Dividend History

Dividend / share · sourced from SEC filings
$0.18 Latest / share
+12.1% YoY
+57.6% 5-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 17 years · 65 quarters